14-day Premium Trial Subscription Try For FreeTry Free
$2.89
+0.180 (+6.64%)
At Close: May 07, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 01, 2024 Sell 94 Zeronda Tyler Common Stock
Apr 01, 2024 Sell 157 Stuart Iain Common Stock
Apr 01, 2024 Sell 161 Harsch Mutya Common Stock
Apr 01, 2024 Sell 1 004 Domzalski David Common Stock
Jan 02, 2024 Sell 93 Zeronda Tyler Common Stock
Jan 02, 2024 Sell 157 Stuart Iain Common Stock
Jan 02, 2024 Sell 161 Harsch Mutya Common Stock
Jan 02, 2024 Sell 1 004 Domzalski David Common Stock
Jan 01, 2024 Buy 62 500 Zeronda Tyler Common Stock
Jan 01, 2024 Buy 62 500 Zeronda Tyler Stock Option (right to buy)
Jan 01, 2024 Buy 62 500 Stuart Iain Common Stock
Jan 01, 2024 Buy 62 500 Stuart Iain Stock Option (right to buy)
Jan 01, 2024 Buy 62 500 Harsch Mutya Common Stock
Jan 01, 2024 Buy 62 500 Harsch Mutya Stock Option (right to buy)
Jan 01, 2024 Buy 225 000 Domzalski David Common Stock
Jan 01, 2024 Buy 225 000 Domzalski David Stock Option (right to buy)
Jan 01, 2024 Buy 20 000 Sandoval Elisabeth Stock Option (right to buy)
Jan 01, 2024 Buy 20 000 Lepore Patrick G Stock Option (right to buy)
Jan 01, 2024 Buy 20 000 Bruno Anthony D Stock Option (right to buy)
Jan 01, 2024 Buy 20 000 Basta Steven L Stock Option (right to buy)
Jan 01, 2024 Buy 20 000 Barbari Sharon Stock Option (right to buy)
Jan 01, 2024 Buy 40 000 Borowski Christine Stock Option (right to buy)
Dec 29, 2023 Buy 0 Borowski Christine
Dec 13, 2023 Buy 62 500 Zeronda Tyler Common Stock
Dec 13, 2023 Buy 62 500 Zeronda Tyler Stock Option (right to buy)
Dec 13, 2023 Buy 62 500 Stuart Iain Common Stock
Dec 13, 2023 Buy 62 500 Stuart Iain Stock Option (right to buy)
Dec 13, 2023 Buy 62 500 Harsch Mutya Common Stock
Dec 13, 2023 Buy 62 500 Harsch Mutya Stock Option (right to buy)
Dec 13, 2023 Buy 225 000 Domzalski David Common Stock
Dec 13, 2023 Buy 225 000 Domzalski David Stock Option (right to buy)
Dec 13, 2023 Buy 20 000 Sandoval Elisabeth Stock Option (right to buy)
Dec 13, 2023 Buy 20 000 Lepore Patrick G Stock Option (right to buy)
Dec 13, 2023 Buy 20 000 Bruno Anthony D Stock Option (right to buy)
Dec 13, 2023 Buy 20 000 Basta Steven L Stock Option (right to buy)
Dec 13, 2023 Buy 20 000 Barbari Sharon Stock Option (right to buy)
Nov 30, 2023 Buy 2 284 Domzalski David Common Stock
Nov 15, 2023 Buy 13 000 Lepore Patrick G Common Stock
Nov 01, 2023 Buy 0 Ai Biotechnology Llc Common Stock
Nov 01, 2023 Buy 7 792 448 Ai Biotechnology Llc Warrant (right to buy)
Oct 02, 2023 Sell 1 087 Zeronda Tyler Common Stock
Oct 02, 2023 Sell 1 184 Stuart Iain Common Stock
Oct 02, 2023 Sell 1 154 Harsch Mutya Common Stock
Oct 02, 2023 Sell 8 549 Domzalski David Common Stock
Jun 30, 2023 Sell 91 Zeronda Tyler Common Stock
Jun 30, 2023 Sell 151 Stuart Iain Common Stock
Jun 30, 2023 Sell 157 Harsch Mutya Common Stock
Jun 30, 2023 Sell 981 Domzalski David Common Stock
May 31, 2023 Buy 3 664 Harsch Mutya Common Stock
May 31, 2023 Buy 2 766 Domzalski David Common Stock
Mar 31, 2023 Sell 384 Zeronda Tyler Common Stock
Mar 31, 2023 Sell 480 Stuart Iain Common Stock
Mar 31, 2023 Sell 478 Harsch Mutya Common Stock
Mar 31, 2023 Sell 2 734 Domzalski David Common Stock
Mar 20, 2023 Buy 20 000 Lepore Patrick G Common Stock
Mar 20, 2023 Buy 10 000 Harsch Mutya Common Stock
Dec 31, 2022 Sell 1 813 Harsch Mutya Common Stock
Dec 31, 2022 Sell 1 720 Stuart Iain Common Stock
Dec 31, 2022 Sell 354 Zeronda Tyler Common Stock
Dec 31, 2022 Sell 10 685 Domzalski David Common Stock
Nov 30, 2022 Buy 34 705 Domzalski David Common Stock
Sep 30, 2022 Sell 353 Zeronda Tyler Common Stock
Sep 30, 2022 Sell 1 719 Stuart Iain Common Stock
Sep 30, 2022 Sell 1 813 Harsch Mutya Common Stock
Sep 30, 2022 Sell 10 683 Domzalski David Common Stock
Aug 10, 2022 Buy 20 500 Sandoval Elisabeth Stock Options
Aug 10, 2022 Buy 20 500 Sandoval Elisabeth Stock Options
Aug 10, 2022 Buy 20 500 Lepore Patrick G Stock Options
Aug 10, 2022 Buy 20 500 Lepore Patrick G Stock Options
Aug 10, 2022 Buy 20 500 Bruno Anthony D Stock Options
Aug 10, 2022 Buy 20 500 Bruno Anthony D Stock Options
Aug 10, 2022 Buy 20 500 Basta Steven L Stock Options
Aug 10, 2022 Buy 20 500 Barbari Sharon Stock Options
Aug 10, 2022 Buy 20 500 Barbari Sharon Stock Options
Jun 30, 2022 Sell 354 Zeronda Tyler Common Stock
Jun 30, 2022 Sell 1 719 Stuart Iain Common Stock
Jun 30, 2022 Sell 1 813 Harsch Mutya Common Stock
Jun 30, 2022 Sell 10 683 Domzalski David Common Stock
May 31, 2022 Buy 12 510 Zeronda Tyler Common Stock
May 31, 2022 Buy 11 887 Domzalski David Common Stock
Mar 31, 2022 Sell 773 Zeronda Tyler Common Stock
Mar 31, 2022 Sell 3 469 Stuart Iain Common Stock
Mar 31, 2022 Sell 3 630 Harsch Mutya Common Stock
Mar 31, 2022 Sell 23 186 Domzalski David Common Stock
Mar 17, 2022 Buy 75 000 Zeronda Tyler Stock Options
Mar 17, 2022 Buy 75 000 Stuart Iain Common Stock
Mar 17, 2022 Buy 75 000 Stuart Iain Stock Options
Mar 17, 2022 Buy 75 000 Stuart Iain Stock Options
Mar 17, 2022 Buy 75 000 Harsch Mutya Common Stock
Mar 17, 2022 Buy 75 000 Harsch Mutya Stock Options
Mar 17, 2022 Buy 75 000 Harsch Mutya Stock Options
Mar 17, 2022 Buy 312 302 Domzalski David Common Stock
Mar 17, 2022 Buy 312 303 Domzalski David Stock Options
Dec 31, 2021 Sell 206 Zeronda Tyler Common Stock
Dec 31, 2021 Sell 1 250 Stuart Iain Common Stock
Dec 31, 2021 Sell 1 484 Harsch Mutya Common Stock
Dec 31, 2021 Sell 6 887 Domzalski David Common Stock
Nov 30, 2021 Buy 4 187 Zeronda Tyler Common Stock
Nov 30, 2021 Buy 12 500 Lepore Patrick G Common Stock
Nov 30, 2021 Buy 4 705 Domzalski David Common Stock
JSON CSV
INSIDER POWER
94.411
Last 100 transactions
Buy: 11 148 761 | Sell: 104 855 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 94.411.

In total, the insiders bought 11 148 761 and sold 104 855 VYNE shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Vyne Therapeutics Inc

Vyne Therapeutics VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing various therapeutics for the treatment of immuno-inflammatory conditions. The company develops FCD105, a topical combination foam that has completed Phase III clinical trials for the treatment of moderate-to-severe acne vulgaris; and FMX114, a combination of tofacitinib, which is in Phase IIa preclinical trial for the treatment of mild-to-moderate atopic dermatitis. It is als... VYNE Profile

Golden Star

Ticker Date Change Price
BBCA May 03 1.26% $65.44
ADTH May 03 5.56% $3.24
ISTB May 03 0.0425% $47.11
WMT May 03 1.34% $59.82
UNP May 03 0.84% $240.36
INGR May 03 1.75% $114.56
ASH May 03 2.26% $95.85
WU May 03 0.449% $13.37
INVH May 03 1.72% $34.39
INTU May 03 1.89% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT